CR Medical held a 2023 annual results conference

On March 20, CR Medical held its annual results 2023 in the 50th floor conference hall of the CR Building in Hong Kong. The management shared the highlights of the 2023 year, the financial performance and future development strategy of the company. The executive director and Chairman Song Qing , the executive director and Chief Executive Officer Yu Hai, the executive director and vice president Shan Baojie, the executive director and Chief Financial Officer, Yang Min , and the independent non-executive director Fu Tingmei attended the meeting.

At the meeting, the management reviewed the full-year performance of CR Medical. Core indicators achieved significant growth, the level of profits rose significantly. During the reporting period, CR medical revenue increased by 27.9 percent year-on-year to RMB 10.108 billion yuan compared with the 2022 re-ranking, and adjusted net profit attributable to the mother increased by 57.0 percent year-on-year compared with the 2022 re-ranking to RMB 644 million yuan.

As a leading state-owned hospital group, CR Medical has made full use of its advantages as a group to accelerated its integration into the regional medical planning territory and fully released the vitality of the organization through an enterprise-based mechanism. It promoted the core competence of subject construction, patient service and Operation Management in an innovative way, and realized the reasonable increase of quantity and effective improvement of quality. During the reporting period, CR Medical completed the acquisition of Healthcare Liaoning and Medical Jiangneng, which further expanded the distribution of member hospital networks. The member hospitals had made remarkable progress in developing their high-quality services and continuously improved the competitiveness of their disciplines. It gave full play to technical advantages and leading by disciplines and gradually increased  investment in disciplines. It continuously improved core competencies around the operational model of medical services. At the same time, it actively promoted the construction of ESG to achieve economic and social benefits win-win.

Chief Executive Officer Yu Hai  said that the medical industry is a pillar industry, which is vital to the national economy and People's livelihood. With the deepening of population ageing and the improvement of People's living standards, our country medical service market space will continue to maintain the rapid growth. Under the guidance of policy and the pressure of competition, the future industry integration space is huge, and the trend of medical collectivization will be more and more clear. CR Medical has outstanding core ability, characteristic management way and complete development mode. Its development prospect is broad. The company will base itself on the positioning of strategic emerging industries, focus on the reform of state-owned hospitals,  give full play to the advantages of state-owned medical groups, and fully release organizational vitality, continue to enhance the core competence of subject construction, patient service, operation and management, and construct the medical business operation mode with the characteristics of CR.

Chairman Song Qing and the company's management had in-depth exchanges with investors and responded positively to hot issues in the industry and the company's development.